Oral mucositis is a gastrointestinal irritation that can cause several problems in the human body. It can influence the overall nutritional admission of a person. Oral mucositis is a typical medical problem arising from disease therapy and different factors. It causes several problems that include torment, nutritional problems as a result of failure to eat, and an increased risk of disease due to open sores in the mucosa.
The increasing pervasiveness of head and neck disease is an essential driving element for the development of the market. As per the American Society of Clinical Oncology (ASCO’s) 2021 report, roughly 4% of individuals suffer from head and neck disease in the U.S., and an estimate of 66,630 individuals (48,740 men and 17,890 ladies) were supposed to foster head and neck malignant growth.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
The central members in the U.S. are focusing on fundraising activities for boosting research and improvement of the therapy of critical oral mucositis caused due to chemotherapy and radiation in the disease patients. For instance, in September 2018, Galera Therapeutics, Inc., announced that the organization secured US$ 150 million in a joint, oversubscribed Series C supporting and sovereignty purchase understanding. The support was driven by new investor Clarus with interest from extra new investors ATekla Capital Management LLC., Rock Springs Capital, RA Capital, Nan Fung Life Sciences, HBM Healthcare Investments, and Adage Capital Management. The existing investors such as Sofinnova Ventures, Novo Ventures, Novartis Venture Fund, New Enterprise Associates, Galera Angels, and Correlation Ventures also took part.
Effects of Coronavirus Pandemic
The coronavirus (COVID-19) pandemic and lockdown in various countries across the globe have affected the monetary status of businesses in all sectors. The private medical services sector is one of the sectors, which is significantly affected by the COVID-19 pandemic. Also, the coronavirus pandemic has negatively affected the turn of events, production, and supply of pharmaceutical products, and impacted the development of several oral mucositis medicine businesses of various companies across the regions such as North America (U.S.). The coronavirus pandemic prompted an unprecedented lockdown in several countries such as the U.S. The lockdown measured led to the closure of industrial establishments aside from manufacturing essential commodities and disruption in the supply chain of pharmaceutical products. Thus, the COVID-19 pandemic has impacted the economy in three fundamental ways; 1) by straightforwardly influencing production and demand; 2) by making disruptions in distribution channels, and 3) by its monetary effect on firms and monetary markets.
Supply chain and manufacturing activities in India, Italy, Spain, the U.K., and the U.S. have been disrupted due to lockdowns executed by various governments in the past couple of months, while countries such as Egypt, UAE, Saudi Arabia, Russia, France, and Brazil, and others are dealing with problems with regards to transportation of drug products. Due to a severe shortage of clinical resources at the bleeding edge, just patients diagnosed with critical health conditions are being admitted to hospitals. However, the pathogenicity of the virus has not been understood totally, even though vaccines and drugs are being manufactured by various companies to forestall and treat COVID-19. The COVID-19 pandemic has affected the global economy and thusly, the U.S. severe oral mucositis market. Quarantine, voyaging constraints, and social distancing measures are probably going to cause a steep decrease in business and consumer spending until the finish of the first quarter of 2021.
Request PDF Brochure with Latest Insights @
Major Point cover in this U.S. Severe Oral Mucositis Market report are: –
The main considerations that ruin the development of the U.S. severe oral mucositis market include the high price related to treating severe oral mucositis in patients. For instance, as per the report published by Oxford University Press in 2019, patients undergoing chemotherapy and radiation treatment for the therapy of head and neck cancers need to pay the gradual cost for the therapy of complications associated with the treatments such as severe oral mucositis. As indicated by the same source, patients need to pay an extra US$ 5,000-30,000 for the therapy of oral mucositis that was induced due to radiation treatment while patients needed to pay US$ 3,700 for every chemotherapy session in the U.S. This treatment cost included hospitalization fees, medicine costs and others.
Central players working in the U.S. severe oral mucositis market are Covis Pharma Group, Amgen, Inc., Galera Therapeutics, Inc., Enzychem Lifesciences, Oragenics, Inc., Soligenix, Inc., Monopar Therapeutics Inc., and Innovation Pharmaceuticals Inc.
Reasons to buy this U.S. Severe Oral Mucositis Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging U.S. Severe Oral Mucositis Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging U.S. Severe Oral Mucositis Market
◘ Leading company profiles reveal details of key U.S. Severe Oral Mucositis Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging U.S. Severe Oral Mucositis Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of U.S. Severe Oral Mucositis Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of U.S. Severe Oral Mucositis Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 U.S. Severe Oral Mucositis Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: U.S. Severe Oral Mucositis Industry Impact
Chapter 2 Global U.S. Severe Oral Mucositis Competition by Types, Applications, and Top Regions and Countries
2.1 Global U.S. Severe Oral Mucositis (Volume and Value) by Type
2.3 Global U.S. Severe Oral Mucositis (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global U.S. Severe Oral Mucositis Sales, Consumption, Export, Import by Regions
Chapter 5 North America U.S. Severe Oral Mucositis Market Analysis
Chapter 6 East Asia U.S. Severe Oral Mucositis Market Analysis
Chapter 7 Europe U.S. Severe Oral Mucositis Market Analysis
Chapter 8 South Asia U.S. Severe Oral Mucositis Market Analysis
Chapter 9 Southeast Asia U.S. Severe Oral Mucositis Market Analysis
Chapter 10 Middle East U.S. Severe Oral Mucositis Market Analysis
Chapter 11 Africa U.S. Severe Oral Mucositis Market Analysis
Chapter 12 Oceania U.S. Severe Oral Mucositis Market Analysis
Chapter 13 South America U.S. Severe Oral Mucositis Market Analysis
Chapter 14 Company Profiles and Key Figures in U.S. Severe Oral Mucositis Business
Chapter 15 Global U.S. Severe Oral Mucositis Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027